Literature DB >> 15992788

Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.

Mark G Jones1, Elizabeth Cooper, Saira Amjad, C Stewart Goodwin, Jeffrey L Barron, Ronald A Chalmers.   

Abstract

Previous work by others have suggested the occurrence of one or more chemical or metabolic 'markers' for ME/CFS including specific amino acids and organic acids and a number of unidentified compounds (CFSUM1, CFSUM2). We have shown elsewhere that CFSUM1 is partially derivatised pyroglutamic acid and CFSUM2 partially derivatised serine and have suggested and demonstrated that the analytical methods used were unsuitable to identify or to accurately quantify urinary metabolites. We have now made a detailed analysis of plasma and urinary amino acids and of urinary organic acids from patients with ME/CFS and from three control groups. Fasting blood plasma and timed urine samples were obtained from 31 patients with CFS, 31 age and sex-matched healthy controls, 15 patients with depression and 22 patients with rheumatoid arthritis. Plasma and urinary amino acids and urinary organic acids were determined using established and validated methods and data compared by statistical analysis. None of the previously reported abnormalities in urinary amino acids or of organic acids could be confirmed. Results however provide some evidence in patients with ME/CFS for underlying inflammatory disease and for reduced intramuscular collagen with a lowered threshold for muscle micro-injury. These factors in combination may provide a basis for the fatigue and muscle pain that are the major symptoms in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15992788     DOI: 10.1016/j.cccn.2005.05.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

Authors:  Arnaud Germain; David Ruppert; Susan M Levine; Maureen R Hanson
Journal:  Mol Biosyst       Date:  2017-01-31

Review 2.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

3.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

4.  Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment.

Authors:  Izabella Surowiec; Clara Gram Gjesdal; Grete Jonsson; Katrine Brække Norheim; Torbjörn Lundstedt; Johan Trygg; Roald Omdal
Journal:  Rheumatol Int       Date:  2016-01-23       Impact factor: 2.631

5.  A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2012-09-17

Review 6.  A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).

Authors:  Teilah Kathryn Huth; Natalie Eaton-Fitch; Donald Staines; Sonya Marshall-Gradisnik
Journal:  J Transl Med       Date:  2020-05-13       Impact factor: 5.531

7.  Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS.

Authors:  Yu-Tsung Lee; Sui-Qing Huang; Ching-Hao Lin; Li-Heng Pao; Chun-Hui Chiu
Journal:  Molecules       Date:  2022-08-23       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.